Neurorehabilitation Devices Market - By Product Type (Neurorobotics, Wearable Devices, BCI, Non-Invasive Stimulators), By Application (Stroke, MS, Parkinsons Disease, Spinal Cord Injury), By End-use (Hospitals, Specialty Clinics) & Forecast, 2024-2032
Neurorehabilitation devices market size is projected to expand at over 13.4% from 2024 to 2032. The increasing prevalence of neurological disorders coupled with the growing aging population is fueling the demand for effective rehabilitation solutions. The rapid technological advancements, including robotic-assisted devices and virtual reality-based therapies are leading to enhanced efficacy of neurorehabilitation. For instance, in February 2023, a provider of digital neuro-therapeutics solutions, MindMaze, launched Izar, a first-of-its-kind smart peripheral for patients with impaired hand motor function, approved by the U.S. FDA and CE-marked from the EU.
The rising awareness about the benefits of early intervention and rehabilitation in neurological conditions will drive the adoption of neurorehabilitation devices. Additionally, the presence of supportive government initiatives is favoring the integration of personalized and home-based rehabilitation solutions. The ongoing R&D activities, focusing on innovations in neurorehabilitation devices will further boost the industry growth.
The neurorehabilitation devices market is segregated into product type, application, end-use, and region.
Based on product type, the industry share from the wearable devices segment is projected to witness 13.7% CAGR from 2024 to 2032. The growth can be attributed to the increasing adoption of portable and user-friendly neurorehabilitation solutions. Wearable devices offer continuous monitoring and personalized rehabilitation experiences for enhancing patient engagement. Moreover, the convenience of incorporating rehabilitation into daily activities and the integration of advanced sensor technologies will fuel the product demand.
Neurorehabilitation devices market from the spinal cord injury application segment may strike a 13% CAGR from 2024 to 2032, owing to the rising incidences of spinal cord injuries. Advanced neurorehabilitation devices help in functional recovery, muscle strengthening, and improving mobility, further contributing to enhanced rehabilitation outcomes for individuals with spinal cord injuries.
Regionally, the Asia Pacific neurorehabilitation devices industry is projected to expand at 13.7% CAGR between 2024 and 2032. The growth can be ascribed to the increasing prevalence of neurological disorders, growing aging population, and rising awareness about advanced rehabilitation solutions. Furthermore, the improvements in healthcare infrastructure and the increasing adoption of technologically advanced neurorehabilitation devices will drive the regional market expansion.